Jingwei Shao

10.3k total citations · 3 hit papers
125 papers, 8.8k citations indexed

About

Jingwei Shao is a scholar working on Molecular Biology, Biomedical Engineering and Oncology. According to data from OpenAlex, Jingwei Shao has authored 125 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 36 papers in Biomedical Engineering and 21 papers in Oncology. Recurrent topics in Jingwei Shao's work include Nanoplatforms for cancer theranostics (25 papers), RNA Interference and Gene Delivery (18 papers) and Nanoparticle-Based Drug Delivery (16 papers). Jingwei Shao is often cited by papers focused on Nanoplatforms for cancer theranostics (25 papers), RNA Interference and Gene Delivery (18 papers) and Nanoparticle-Based Drug Delivery (16 papers). Jingwei Shao collaborates with scholars based in China, United States and Singapore. Jingwei Shao's co-authors include Yuwu Chi, Yongqiang Dong, Guonan Chen, Chunxian Guo, Ting Yu, Xiaomei Lin, Hongchang Pang, Ruixue Wang, Hong Yang and Chang Ming Li and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Jingwei Shao

120 papers receiving 8.7k citations

Hit Papers

Carbon‐Based Dots Co‐doped with Nitrogen and Sulfur for H... 2012 2026 2016 2021 2013 2012 2012 500 1000 1.5k 2.0k

Peers

Jingwei Shao
Jingwei Shao
Citations per year, relative to Jingwei Shao Jingwei Shao (= 1×) peers Xueyun Gao

Countries citing papers authored by Jingwei Shao

Since Specialization
Citations

This map shows the geographic impact of Jingwei Shao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jingwei Shao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jingwei Shao more than expected).

Fields of papers citing papers by Jingwei Shao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jingwei Shao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jingwei Shao. The network helps show where Jingwei Shao may publish in the future.

Co-authorship network of co-authors of Jingwei Shao

This figure shows the co-authorship network connecting the top 25 collaborators of Jingwei Shao. A scholar is included among the top collaborators of Jingwei Shao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jingwei Shao. Jingwei Shao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Chenglei, et al.. (2025). Self-oxygenating nanoplatform integrating CRISPR/Cas9 gene editing and immune activation for highly efficient photodynamic therapy. Journal of Colloid and Interface Science. 693. 137632–137632. 1 indexed citations
2.
Hu, Yongshan, et al.. (2024). Recent research progress based on ferroptosis-related signaling pathways and the tumor microenvironment on it effects. European Journal of Medicinal Chemistry. 269. 116290–116290. 2 indexed citations
3.
Wang, Ying, et al.. (2024). Renewable generation forecasting with DNN-based ensemble method in electricity scheduling. Frontiers in Energy Research. 12.
5.
Zhang, Bingchen, et al.. (2024). A natural product-derived nanozyme regulator induced chemo-ferroptosis dual therapy in remodeling of the tumor immune microenvironment of hepatocellular carcinoma. Chemical Engineering Journal. 482. 148976–148976. 11 indexed citations
6.
Le, Jingqing, et al.. (2023). Synergistic anti-tumor effect of dual drug co-assembled nanoparticles based on ursolic acid and sorafenib. Colloids and Surfaces B Biointerfaces. 234. 113724–113724. 10 indexed citations
7.
Zhang, Bingchen, et al.. (2023). Three-pronged attacks by hybrid nanoassemblies involving a natural product, carbon dots, and Cu2+ for synergistic HCC therapy. Journal of Colloid and Interface Science. 650(Pt A). 526–540. 10 indexed citations
8.
Le, Jingqing, et al.. (2023). Dual-drug controllable co-assembly nanosystem for targeted and synergistic treatment of hepatocellular carcinoma. Journal of Colloid and Interface Science. 656. 177–188. 12 indexed citations
9.
Shao, Jingwei, et al.. (2023). A Method for Optimal Allocation of Distributed PV and Energy Storage Based on High Reliability of Distribution Network. Journal of Physics Conference Series. 2527(1). 12017–12017. 1 indexed citations
10.
Le, Jingqing, et al.. (2023). A hemoglobin-based oxygen-carrying biomimetic nanosystem for enhanced chemo-phototherapy and hypoxia alleviation of hepatocellular carcinoma. Journal of Industrial and Engineering Chemistry. 123. 330–341. 5 indexed citations
11.
Wu, Pengyu, Zhichun Shen, Jiali Jiang, et al.. (2022). A multifunctional theranostics nanosystem featuring self-assembly of alcohol-abuse drug and photosensitizers for synergistic cancer therapy. Biomaterials Science. 10(21). 6267–6281. 9 indexed citations
12.
Zhang, Bingchen, Jiali Jiang, Pengyu Wu, et al.. (2020). A smart dual-drug nanosystem based on co-assembly of plant and food-derived natural products for synergistic HCC immunotherapy. Acta Pharmaceutica Sinica B. 11(1). 246–257. 53 indexed citations
13.
Shao, Jingwei, Yifan Fang, Ruirui Zhao, et al.. (2020). Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid. Asian Journal of Pharmaceutical Sciences. 15(6). 685–700. 48 indexed citations
14.
Chen, Fangmin, Yifan Fang, Xiang Chen, et al.. (2020). Recent advances of sorafenib nanoformulations for cancer therapy: Smart nanosystem and combination therapy. Asian Journal of Pharmaceutical Sciences. 16(3). 318–336. 28 indexed citations
15.
Xie, Xiaodong, Huifang Nie, Yu Zhou, et al.. (2019). Eliminating blood oncogenic exosomes into the small intestine with aptamer-functionalized nanoparticles. Nature Communications. 10(1). 5476–5476. 87 indexed citations
16.
Zhu, Kongkai, et al.. (2019). Rational Design, synthesis and biological evaluation of novel triazole derivatives as potent and selective PRMT5 inhibitors with antitumor activity. Journal of Computer-Aided Molecular Design. 33(8). 775–785. 16 indexed citations
19.
Shao, Jingwei, Robert J. Griffin, Ekaterina I. Galanzha, et al.. (2013). Photothermal nanodrugs: potential of TNF-gold nanospheres for cancer theranostics. Scientific Reports. 3(1). 1293–1293. 114 indexed citations
20.
Shao, Jingwei, et al.. (2012). Synthesis and antitumor activity of emodin quaternary ammonium salt derivatives. European Journal of Medicinal Chemistry. 56. 308–319. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026